These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 10369451

  • 1. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S, Taniguchi T, Muramatsu I.
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [Abstract] [Full Text] [Related]

  • 2. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB, Marshall I.
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.
    Nakamura S, Taniguchi T, Suzuki F, Akagi Y, Muramatsu I.
    Br J Pharmacol; 1999 Jul; 127(6):1367-74. PubMed ID: 10455286
    [Abstract] [Full Text] [Related]

  • 4. Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature.
    Murata S, Taniguchi T, Takahashi M, Okada K, Akiyama K, Muramatsu I.
    J Urol; 2000 Aug; 164(2):578-83. PubMed ID: 10893647
    [Abstract] [Full Text] [Related]

  • 5. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, Vimont RL, Chapple CR, Chess-Williams R, Eglen RM, Clarke DE, Ford AP.
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [Abstract] [Full Text] [Related]

  • 6. Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.
    Morishima S, Suzuki F, Yoshiki H, Md Anisuzzaman AS, Sathi ZS, Tanaka T, Muramatsu I.
    Br J Pharmacol; 2008 Apr; 153(7):1485-94. PubMed ID: 18223667
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
    Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, Clarke DE.
    Br J Pharmacol; 1997 Jul; 121(6):1127-35. PubMed ID: 9249248
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML, Budriesi R, Chiarini A, Poggesi E, Leonardi A, Melchiorre C.
    J Med Chem; 1998 Nov 19; 41(24):4844-53. PubMed ID: 9822553
    [Abstract] [Full Text] [Related]

  • 10. Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding.
    Tanaka T, Zhang L, Suzuki F, Muramatsu I.
    Br J Pharmacol; 2004 Feb 19; 141(3):468-76. PubMed ID: 14718262
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.
    Takahashi M, Taniguchi T, Kanamaru H, Okada K, Muramatsu I.
    Life Sci; 2000 Oct 06; 67(20):2443-51. PubMed ID: 11065167
    [Abstract] [Full Text] [Related]

  • 12. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD, Valiente M, Martínez S, Madrero Y, Noguera MA, Cassels BK, Sobarzo EM, D'Ocon P.
    Planta Med; 2005 Oct 06; 71(10):897-903. PubMed ID: 16254819
    [Abstract] [Full Text] [Related]

  • 13. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
    Yamada S, Okura T, Kimura R.
    J Pharmacol Exp Ther; 2001 Jan 06; 296(1):160-7. PubMed ID: 11123376
    [Abstract] [Full Text] [Related]

  • 14. KMD-3213, a novel alpha1A-adrenoceptor antagonist, potently inhibits the functional alpha1-adrenoceptor in human prostate.
    Moriyama N, Akiyama K, Murata S, Taniguchi J, Ishida N, Yamazaki S, Kawabe K.
    Eur J Pharmacol; 1997 Jul 16; 331(1):39-42. PubMed ID: 9274928
    [Abstract] [Full Text] [Related]

  • 15. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK, Blaylock NA, Kendall DA, Wilson VG.
    Br J Pharmacol; 1995 Feb 16; 114(3):678-88. PubMed ID: 7735695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
    Smith KM, Macmillan JB, McGrath JC.
    Br J Pharmacol; 1997 Nov 16; 122(5):825-32. PubMed ID: 9384497
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM.
    Br J Pharmacol; 1996 Jun 16; 118(4):871-8. PubMed ID: 8799556
    [Abstract] [Full Text] [Related]

  • 19. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
    Muramatsu I, Taniguchi T, Okada K.
    Jpn J Pharmacol; 1998 Nov 16; 78(3):331-5. PubMed ID: 9869267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.